| Mar 1 2023 |
Desperate Times, Desperate Measuring Cups – FTC Brings Enforcement Action for False “Made in USA” Advertising |
ArentFox Schiff LLP |
| Mar 1 2023 |
Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests |
Epstein Becker & Green, P.C. |
| Feb 28 2023 |
FDA Asked to Allow “Healthy” Claims on Coffee |
Keller and Heckman LLP |
| Feb 28 2023 |
China Announces Draft Standard on Nutritional Fortification Substances: What Will its Impact Be on Alternative Protein Foods? |
Keller and Heckman LLP |
| Feb 28 2023 |
Will the U.S. Supreme Court Make Marijuana Legal? |
Bradley Arant Boult Cummings LLP |
| Feb 28 2023 |
This Week in 340B: February 21 – 27, 2023 |
McDermott Will & Schulte LLP |
| Feb 27 2023 |
Old North State Report – Feb. 27, 2023 |
Nelson Mullins |
| Feb 27 2023 |
FDA Publishes List of 2023 Priority Guidance Topics |
Keller and Heckman LLP |
| Feb 27 2023 |
DEA Announces Permanent Flexibilities for the Prescribing of Controlled Substances via Telemedicine |
Polsinelli PC |
| Feb 27 2023 |
DEA’s Proposed Rules on Telemedicine Controlled Substances Prescribing after the PHE Ends |
Foley & Lardner LLP |
| Feb 25 2023 |
No Surprises Act Update: Certified IDR Entities to Resume Payment Determinations for Services Furnished Before October 25, 2022 |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 25 2023 |
HHS-OIG Declines to Impose Sanctions on Drug Manufacturer for Financial Assistance to Pediatric Patients with Rare Disease |
Barnes & Thornburg LLP |
| Feb 24 2023 |
Cosmetics – Moving From Voluntary Compliance to Mandatory Regulation |
Beveridge & Diamond PC |
| Feb 24 2023 |
From the Year of the Tiger to the Year of the Rabbit |
Keller and Heckman LLP |
| Feb 24 2023 |
FDA Files Civil Money Penalty Complaints Against Four Small Vape Shops for Alleged Premarket Review Violations |
Keller and Heckman LLP |
| Feb 24 2023 |
Tenth Circuit Declares No Remedy for Hemp Farmer Whose Federally Legal Plants Were Seized |
ArentFox Schiff LLP |
| Feb 24 2023 |
FDA Releases Draft Guidance on Labeling of Plant-Based Milk Alternatives |
Keller and Heckman LLP |
| Feb 23 2023 |
Coverage for Rotten Eggs: Livestock Coverage in the Event of a Crisis |
Hunton Andrews Kurth |
| Feb 23 2023 |
Modified REMS, Clarification on Mailing Drugs, and Movement in Texas Case Mark Significant Weeks in the Reproductive Health Legal Sphere |
ArentFox Schiff LLP |
| Feb 23 2023 |
THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances |
Bradley Arant Boult Cummings LLP |
| Feb 23 2023 |
Walking the Highwire of Affiliate Marketing and Advertising Claims [PODCAST] |
Greenberg Traurig, LLP |
| Feb 22 2023 |
CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 21 2023 |
Lawsuit Alleges PFAS in Pomegranate Juice |
Keller and Heckman LLP |
| Feb 21 2023 |
The 2023 Farm Bill and the Future of Hemp |
Bradley Arant Boult Cummings LLP |
| Feb 20 2023 |
Old North State Report – Feb. 20, 2023 |
Nelson Mullins |
| Feb 18 2023 |
EPA Announces Both EPA and FDA Seek Public Input on Modernizing Their Approach to Oversight of Certain Products |
Bergeson & Campbell, P.C. |
| Feb 17 2023 |
Delta-What??!!- Delta-8 and Delta-9 Create High Anxiety for Policymakers |
Norris McLaughlin P.A. |
| Feb 17 2023 |
Bankruptcy Court Dismisses Cannabis Company Employee’s Chapter 13 Case |
Squire Patton Boggs (US) LLP |
| Feb 17 2023 |
FDA Sued for Denying Petition Related to Antibiotic Use |
Keller and Heckman LLP |
| Feb 16 2023 |
FDA Issues Guidance on Protein Quality Studies for Infant Formula |
Keller and Heckman LLP |
| Feb 15 2023 |
You Can Go Your Own Way: Washington’s Cannabis License Residency Requirement Upheld, Breaking the Chain of Contrary Decisions |
Bradley Arant Boult Cummings LLP |
| Feb 14 2023 |
FDA Issues Warning Letter to RightEye, LLC For Misbranding and Adulteration |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 14 2023 |
CVM Holds Virtual Meeting on AAFCO Feed Ingredient Definition Process |
Keller and Heckman LLP |
| Feb 13 2023 |
REGULATORY YEARLY WRAP 2022: Medical Devices in India |
Nishith Desai Associates |
| Feb 13 2023 |
Old North State Report – Feb. 13, 2023 |
Nelson Mullins |
